X. Li

Postmarketing safety of orphan drugs: a longitudinal analysis of the US Food and Drug Administration database between 1999 and 2018

P. Ip, Xinning Tong, I. Wong, 2022, Orphanet Journal of Rare Diseases.

Budget impact of introducing tofacitinib to the public hospital formulary in Hong Kong, 2017-2021.

S. Pathadka, X. Li, K. K. Man, 2019, Hong Kong medical journal = Xianggang yi xue za zhi.

Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong

Xia Li, E. Wan, F. Lai, 2021, Journal of Autoimmunity.

Budget impact and cost-effectiveness analyses of direct-acting antivirals for chronic hepatitis C virus infection in Hong Kong

I. Hung, E. Chan, N. Chan, 2017, European Journal of Clinical Microbiology & Infectious Diseases.

Short- and potential long-term adverse health outcomes of COVID-19: a rapid review

C. Siu, B. Cowling, W. Leung, 2020, Emerging microbes & infections.

Bleeding‐related hospital admissions and 30‐day readmissions in patients with non‐valvular atrial fibrillation treated with dabigatran versus warfarin

Kenneth K C Man, G. Lip, C. Siu, 2017, Journal of thrombosis and haemostasis : JTH.